>YP_009408395.1 |surface glycoprotein [NY_014 poxvirus]
MNLYILSLIIYFATCSWCYETCMRKSALYHDNNLDRVEDNKDDVASLPYKYLQVVHQRES
SRLLATFNWTSISNSVREEFVKRCDINGTYLYNYTIAISMIINSTEELLTSPIQTTTQTP
TPSPTQYYYTTPLPTSIVPYNQSNNNVSIISIQILSKILGVNESELTSYLITHINNTVVY
NETYNNTVVYNEASNNNTLNGNIGLFEINNCYNVSVADASFRITLVNETSEEIVLMLKGT
SASDTFISSDNITECLRTLINNTSNNTDVTITENVNVTSNCDKCSMDLMTSVVPIVTEFN
NTLEKIGAKYSNTTYSYYHCKLTTNSNCNELINLNEIINNITLTNIISSSSKTNTRKRRD
LNPEIGFSTPKELDCLYESYGVKDDVSHCFASPRHRRSDDKEYIEMKLLDHAKRDLGIDS
VIPRGTTHFQVGVSGASGGVVGDSSPFQNVKSRASLLAEKIMPKVPITTTEDDLYATVNK
QAKLPAGVKSTPFTEAVVSTINQKLSSVKDVTYASLELPRSSGYIHRPSESVIYSTIRRP
RISSSSSSDFEDIDTVVKEYNQKYGGRVRTLSSSSDFEDIDTVVKEYNQKYGGRVRTLSS
NSDFEDIDTVVKEYNQKYGNAMTRGRSTSPKPDPLYSTVKKTPKSLAAGVEIATKQTEYS
ILPDVNTGSSIMTPLTRRGATRRPKRPSPPSSNNLPPLPPNPPPRNPRPQLPPRDDSSPP
RRPPPPLPPKPVPAVPPRDSQPDKKGFSKFVSPRRCRRASSGVICGLIQSRPNDDTYSLL
QPPNRNYPQYEEVGNGIARNNVPVIGDKRSKKYTSSMTKISTKFDKSMAFGAAMLLTGQQ
AINQQIRSTALIRKDQMSKEEKIFEAVSMGLSSIGSTLTTAGMVAGPKLMIAGMGVSFIA
GIIDTVKDIYYLLSGAERPEDPVIKLFNTYSDLVSDSNKMGVRKCLTPGEDTIIFMAYKN
DSSFKPNIDNAIYFLDVINSEILYLNTSNLVLEYQLKVACPIGTLRSVDVDITAYTVLYD
TSDNIKRYKFVRLATLLSKHPVIRLTCGLDATLVIKPYEVPISDMQLLKMATPGEPESTK
SIPSDVCDKYPLKKFYLLASGCPYDTSQTFIVHTTCSILLKTATWDQFRNRWVLQNPFKQ
EGTFKQLFTFSKYDFNDTIIDPNGVEGHASFCTNKSSNQCFWSEPMILEDVTSCNSRTRK
IYVKLGLFNTGGFNSFVLNCPSGSTPTYIKDKNTDNSNFIIELPVGDYGTAKLYSSTKQS
RIAVFCTHNYDKRFKSDIIVLIFDRFSSLSFTSIDTTGVYGKNTLFYRLSGGMPFRSLFC
DNRRRAGCNYAGIPFNEESVEIDVHHGSEIMFKETYDANSVDPVIISKSKTHFPSPLNIK
FHVNNLGNGYKNHDSFWKDAKNKKRTYSAITLKISPCTIRNKNIDFGPFVSNMVYLQSTS
YDYGDGSKYTFKSVNKTNHECEASLDLTSKEVIVTCPAFSIPRNISKYEGLCFTIVTSKD
HCATNDDGLKSHGYEKEDAYKQRYCHHHWLYNIKPYDYYCMDSYFKHRFPDYDPCNSYIN
VEYRDTWIESKVLQQPPYTFEFIHDDSNEYVDKEISNKLNDLYNEYKNIMEYSDGSLPAS
INRLAKALTLEGREITSVNIDGNLLDIAYQADKEKMIEIQNKIDDITRDLFIHTLSDKDI
KDIIESEEGKRCCIIDVKNNHVEKYYPIDNYLCGTLDDYIYTSVETNKSYVLVNDTYMSY
DYLEASGIVVLSCYEMTIISLDTKDAKDAVENEIIESAVAEALNDMFKEFDKNVSAILIK
EEDNYLNNKDIYNIIYIIGSAILLLLVIVLILVMYIALNRYKTRKYKLIKKYDNISIKSE
HHNSLETISMEIIDH
>AXN74997.1 |surface glycoprotein [Akhmeta virus]
MNLHRLSLAIYLTATCSWCYETCMRKSALYHDNKLGHMDESQDNVASLPYKYLQLVHKRE
RSRLLATFNWPSITNSVRGEFIKICNINGSYIYNYTIAVSMVINSTEELPVTPITTVSPQ
LTTHPLTTPQLTTHPLTTPPQTTPPPTTLPPLTTPSYDQRSNNNVSVISIQILSRILGVN
ETVLTNYLITHRNATADNTTSVINNHTVDDATFGNNTLNGSIGVLNITNCYNVSVLDASF
EITLVNDTSEEIVLMLRGTSSSDTFISSDNITECLKALINNASNVSDVSITQNINVTSNC
DKCSMNLMTSVIPIVSEYNDTLEKIGVKKDDNTTHAYYYCKLTTNSTCNELINLDSVINN
ITLTNIISSSSTATNNKRKRRDLDNEFEYSTSKELDCLYESYGVNDDVRHCFASPRHRRS
DDKQAYIEMKLLDHAKRDLGLDRIIPRGTTHLQVGASGASGGVVGDSSPFQNVKSRASLL
AEKIMPRVPITATESDLYAVVNKQPKLPAGVKSTPFTEALASTITQKLSSAREVTYASLN
LPRSSGVIHKPPDSVIYSTIRRTRLPSDSDSDFEDIQTVVREYNERYGRRVSRTSSSSSS
DFEDVGAVAREYNEKYGSDSRLRTVSSSSSDFEDIETVVREYKEKYGNAMTKGRSSSPKP
DQLYSTVKKTPKSIASGVEIVTSQSGYSIIPDVNTGSSIMTPLTRRGATRRPKQPTYNDD
LQAPLNPPPRNPRRPLPQRGYHPQVPQDDDYSLPQVPRRDGSPPPLPPRRPPPLPPKPAG
QVPPRDQPDKGFSKFVSPRRCRRSSSGVICGMLQSRPNDDTYSLLQRPNPEPEYAEVGNG
VPRNNVPVIGNKHSKKYTSSMSKISTKFDKSMAFGAAMLLTGQQAISQQSRSSVLSKKDQ
MSKEEKIFEAVTMSLSAIGSTLTSAGMVGGPKLMIAGMGITAITGIIDTIKDIYQLFSGY
EKPEDPVIKLFNTYSGLVSNNDKMGVRKCLTPGEDTIIYMAYRNDSSFKQNNDAMALYFL
DVIDSEILYLNTSNLVLEYQLKVACPIGTLRSMDVDITAYTILYDTSDNIKKYKFVRLAT
LLSKHPVIRLTCGLAATLVIKPYEVPISDMQLLKMATPGEPEFTRSIPSDVCDRYPLKKF
YLLASGCPYDTSQTFIVHTTCSILLKTATWDQFRNRWVLQNPFRQEGTYKQLFTFSKYDF
NDTIIDPNGVAGHASFCTNRSSNQCFWSEPMILEDVSSCNSRTRKIYVRLGRFESSGFNS
FVLNCPTGSTPTYIKDKNTENGNVIIELPVGDYGTAKLYSSTKASRIAVFCTHNYDKRFK
SDIIVIIFDYGTVSYSSIYTGGMSGKRQLFNKFSDGLPYRSTYCDNRRSGCYYAGIPFNE
DSVEADLHYGPEIMFKETYDANSIDQRVITKSKTHFPSPLSVKFIVDNLGHGYNNPNAFW
EDAKTKKRTYSAMSIKILPCTMRNKNVEFGPVISNMLYLQSISQNYGDGSTYTFKPVNSA
EHDCESTLDLTSKEVTVSCPAFSIPRNVSKYEGICFSVTTSKDHCATNNGWLKSRGYGKN
DANRGRSCYHHWFYISRSLDYYCSHQDDWKSTWPDYDPCKSYIYIEYRDTWIESNVLQQP
PYTFEFTHDNSNEYVNKEISDKLNDLYNEYKNIMEYSDGSLPASINRLAKALTSEGREIA
SVNIDGNLLDIAYQADKEKMADIQTRINDITRDLFIHTLSDKDIKDIIESEEGKRCCIID
VKNNRVEKYYPVDNYLCGTLDDYIYTSIEHNKSYVLVNNTYMEYDYLASSGVVVLSCYEM
TIISLDTKDAKDAIEDEIVASAVAEALNDIFKEFDKNVSAIIIKEEDKYLNSPHSNSQDI
YNIIYIIGGSILVLLVIILILAIYIARNKYRTRKYKIMKYDNRSIKSEHHNSLETVSMEI
MDNRY
>QNQ32115.1 |surface glycoprotein [Severe acute respiratory syndrome coronavirus 2]
MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFS
NVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIV
NNATNVVIKVCEFQFCNDHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFK
NLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLLALHRS
YLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETKCTLKSFT
VEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSV
LYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPD
DFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGAEGFN
CYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLT
GTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITPGTNTSNQ
VAVLYQDVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIG
AGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEIL
PVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQ
IYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAAR
DLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFN
GIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQLS
SNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAAT
KMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKA
HFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDS
FKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE
QYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKG
VKLHYT
>QPD96890.1 |surface glycoprotein [Severe acute respiratory syndrome coronavirus 2]
MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFS
NVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIV
NNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLE
GKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQT
LLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETK
CTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISN
CVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIAD
YNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPC
NGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVN
FNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITP
GTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSY
ECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTI
SVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQE
VFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDC
LGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAM
QMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALN
TLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRA
SANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPA
ICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDP
LQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDL
QELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDD
SEPVLKGVKLHYT
>QLA46612.1 |surface glycoprotein [Severe acute respiratory syndrome coronavirus 2]
MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYCPDKVFRSSVLHSTQDLFLPFFS
NVTWFHAIHVSGTNGTKRFDNPVLPSNDGVYFASIGKSNIIRGWIFGTTLDSKTQSLLIV
NNATNVVIKVCEFQFCNDPFLGVYYHKNNKGWMESEFRVYSSANNCTFEYVSQPFLMDLE
GKQGKFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQT
LLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETK
CTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISN
CVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIAD
YNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPC
NGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVN
FNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITP
GTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSY
ECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTI
SVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQE
VFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDC
LGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAM
QMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALN
TLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRA
SANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPA
ICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDP
LQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDL
QELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDD
SEPVLKGVKLHYT
>QNN88166.1 |surface glycoprotein [Severe acute respiratory syndrome coronavirus 2]
MFVFLVSLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFS
NVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIV
NNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLE
GKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQT
LLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETK
CTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISN
CVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIAD
YNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPC
NGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVN
FNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITP
GTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSY
ECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTI
SVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQE
VFAQVKQIYKTPPIKDFGGFNFSQILPDPSKLSKRSFIEDLLFNKVTLADAGFIKQYGDC
LGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAM
QMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALN
TLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRA
SANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPA
ICQDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDP
LQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDL
QELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDD
SEPVLKGVKLHYT
>QOT48869.1 |surface glycoprotein [Severe acute respiratory syndrome coronavirus 2]
MFVFFVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFS
NVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIV
NNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLE
GKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQT
LLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETK
CTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISN
CVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIAD
YNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGNTPC
NGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVN
FNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITP
GTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSY
ECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTI
SVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQE
VFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDC
LGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAM
QMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALN
TLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRA
SANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPA
ICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDP
LQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDL
QELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDD
SEPVLKGVKLHYT
>QOU84470.1 |surface glycoprotein [Severe acute respiratory syndrome coronavirus 2]
MFVFLVLLPLVSSQCVNLTTRTQLTPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFS
NVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIV
NNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLE
GKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQT
LLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETK
CTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISN
CVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIAD
YNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPC
NGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVN
FNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITP
GTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSY
ECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTI
SVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQE
VFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDC
LGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAM
QMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALN
TLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRA
SANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTAPA
ICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDP
LQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDL
QELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDD
SEPVLKGVKLHYT
>QOW62960.1 |surface glycoprotein [Severe acute respiratory syndrome coronavirus 2]
MFVFFVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFS
NVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIV
NNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCTFEYVSQPFLMDLE
GKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQT
LLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETK
CTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISN
CVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIAD
YNYKLPDDFTGCVIAWNSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPC
NGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVN
FNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITP
GTNTSNQVAVLYQGVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSY
ECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTI
SVTTEILPVSMTKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALTGIAVEQDKNTQE
VFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDC
LGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAM
QMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALN
TLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRA
SANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQSAPHGVVFLHVTYVPAQEKNFTTSPA
ICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDP
LQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDL
QELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDD
SEPVLKGVKLHYT
